Jeonjinbio Co., Ltd. (KOSDAQ:110020)
2,260.00
+35.00 (1.57%)
At close: Apr 1, 2026
Jeonjinbio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6,412 | 6,276 | 1,692 | 1,334 | 15,306 |
Short-Term Investments | - | 472.52 | - | - | - |
Cash & Short-Term Investments | 6,412 | 6,748 | 1,692 | 1,334 | 15,306 |
Cash Growth | -4.98% | 298.74% | 26.83% | -91.28% | 71.54% |
Accounts Receivable | 2,029 | 2,452 | 2,803 | 724.02 | 205.04 |
Other Receivables | 12.69 | 2.82 | 5.42 | 5.98 | 4.15 |
Receivables | 2,041 | 2,455 | 2,808 | 1,330 | 209.19 |
Inventory | 992.77 | 921.32 | 1,746 | 1,982 | 602.35 |
Prepaid Expenses | 5.71 | 6.03 | 8.07 | 57.1 | 7.76 |
Other Current Assets | 27.7 | 14.03 | 1,511 | 52.83 | 33.04 |
Total Current Assets | 9,480 | 10,144 | 7,767 | 4,756 | 16,158 |
Property, Plant & Equipment | 9,015 | 8,687 | 9,765 | 10,948 | 7,997 |
Long-Term Investments | - | - | - | -0 | -0 |
Other Intangible Assets | 13.47 | 21.76 | 71.88 | 80.62 | 58.36 |
Long-Term Deferred Charges | - | - | - | 636.91 | 552.08 |
Other Long-Term Assets | 0.2 | 0.2 | 100.28 | 1,503 | 52.32 |
Total Assets | 18,509 | 18,853 | 17,704 | 17,924 | 24,817 |
Accounts Payable | 79.34 | 260.14 | 239.75 | 139.18 | 47.85 |
Accrued Expenses | 422.74 | 445.89 | 521.74 | 485.06 | 337.31 |
Short-Term Debt | - | - | 5,309 | 4,583 | 7,401 |
Current Portion of Leases | - | 92.62 | 288.27 | 1,089 | 7.5 |
Other Current Liabilities | 373.18 | 287.53 | 4,854 | 1,651 | 6,185 |
Total Current Liabilities | 875.26 | 1,086 | 11,213 | 7,947 | 13,979 |
Long-Term Leases | - | - | - | 288.27 | - |
Pension & Post-Retirement Benefits | 225.65 | 105.69 | 227.73 | 60.19 | 1.17 |
Other Long-Term Liabilities | - | - | 43.52 | 63.44 | 41.17 |
Total Liabilities | 1,101 | 1,192 | 11,484 | 8,359 | 14,022 |
Common Stock | 4,529 | 4,529 | 3,742 | 3,420 | 3,171 |
Additional Paid-In Capital | 42,313 | 42,313 | 35,585 | 32,955 | 31,407 |
Retained Earnings | -28,345 | -28,092 | -32,419 | -25,900 | -22,872 |
Comprehensive Income & Other | -1,089 | -1,089 | -688.68 | -910.12 | -910.12 |
Shareholders' Equity | 17,408 | 17,661 | 6,220 | 9,565 | 10,796 |
Total Liabilities & Equity | 18,509 | 18,853 | 17,704 | 17,924 | 24,817 |
Total Debt | - | 92.62 | 5,597 | 5,960 | 7,409 |
Net Cash (Debt) | 6,412 | 6,656 | -3,904 | -4,625 | 7,897 |
Net Cash Growth | -3.66% | - | - | - | 109.09% |
Net Cash Per Share | 720.42 | 773.38 | -535.98 | -702.78 | 1273.53 |
Filing Date Shares Outstanding | 8.43 | 9.06 | 7.48 | 6.84 | 6.34 |
Total Common Shares Outstanding | 8.43 | 9.06 | 7.48 | 6.84 | 6.34 |
Working Capital | 8,605 | 9,058 | -3,446 | -3,191 | 2,179 |
Book Value Per Share | 2065.92 | 1949.65 | 831.11 | 1398.45 | 1702.42 |
Tangible Book Value | 17,395 | 17,640 | 6,148 | 9,485 | 10,737 |
Tangible Book Value Per Share | 2064.32 | 1947.25 | 821.51 | 1386.67 | 1693.21 |
Land | 3,041 | 3,041 | 3,041 | 3,041 | 3,041 |
Buildings | 3,568 | 3,568 | 3,568 | 3,568 | 3,568 |
Machinery | 4,080 | 3,194 | 3,008 | 2,206 | 1,565 |
Construction In Progress | 11.74 | 78 | 268 | 545.59 | - |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.